|
On March 10, 2025, McKesson began using new electronic TagAlert temperature monitors in refrigerated vaccine shipments. These updated monitors function similarly to those used in frozen Moderna COVID-19 vaccine shipments, tracking both warm and cold temperature excursions during transit.
Please see this flyer for information on the new temperature monitor.
For any questions or concerns, please contact your Regional Immunization Nurse or the Nurse on Call at 877-296-0464.
Vaccine Information Statements (VISs) are essential resources provided by the Centers for Disease Control and Prevention (CDC) to educate patients, parents and legal guardians about the benefits and risks of vaccines.
Did you know that health care providers are required by the National Childhood Vaccine Injury Act to distribute the most up-to-date VIS before administering a vaccine? Ensuring patients receive current information helps maintain transparency and trust in the immunization process.
The VISs are updated frequently and available in multiple languages. They can be downloaded from the CDC or Immunize.org websites.
Please discard outdated VISs and replace them with the most current versions to stay compliant and provide accurate information.
Keeping up with updated VISs ensures our patients and families receive the best and most accurate vaccine guidance. Thank you for staying informed and proactive!
The Influenza-Like Illness Surveillance Network (ILINet) sites monitor patients for influenza-like illness (ILI), which is defined as symptoms of a fever (>100⁰F) and the presence of a cough and/or sore throat.
During the week ending March 15, the Kansas Health and Environmental Laboratories reported 10 positive influenza A/H1 specimens and three positive influenza A/H3 specimens.
During the week ending March 15, ILINet sites reported 3% of visits were due to ILI. Syndromic surveillance indicated that 4% of emergency departments visits in Kansas were due to ILI. All data is subject to change. Influenza activity across the state is currently considered moderate.
As a reminder, outbreaks of any disease are reportable and should be reported to the epidemiology hotline at 877-427-7317. Stay updated on influenza activity.
The 340B Drug Pricing Program second quarter registration will take place April 1 to April 15, 2025.
If you have not previously registered or are inactive due to missing the required annual recertification in May 2024, please contact Rachael South, 340B Program Administrator to schedule a time during the registration period for assistance in completing your registration. Rachael can be reached via email or phone number 785-296-0866.
Any 340B covered entity that is currently listed as “active” for the TB or STD designations with HRSA will complete the recertification process, this typically takes place in May. Authorizing Officials and Primary Contacts, please be on the lookout for an email from HRSA in the coming month. The Authorizing Official must verify the covered entity’s compliance with all 340B Program requirements via their OPAIS login during the timeframe that will be specified in the email received from HRSA.
Dr. Erin Corriveau is dedicated to improving access to TB treatment and testing in the Kansas City metropolitan area. She put together a team to review new TB cases and connect patients with necessary resources. Dr. Corriveau established a network of community sites to improve access to TB testing and works to help people with TB disease complete treatment.
Congrats Dr. Erin Corriveau!
Register here for Healthcare Inequities and IPC which will be held March 27, 2025, at 11 a.m. CST.
Register here for CDC Coca Call: Murine Typhus: a re-emerging Threat in the United States which will be held March 27, 2025, at 1 p.m. CST.
Register here for Removing Roadblocks: Practical Approaches to Increase Adult RSV Vaccine Uptake which will be held April 1, 2025, at noon CST.
Check out the full training list.
|
